| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $420.6M | +7.7% |
| Cost of Revenue | $201.3M | +10.9% |
| Gross Profit | $219.2M | +4.9% |
| R&D Expense | $7.4M | +9.7% |
| SG&A Expense | $111.6M | +24.0% |
| Operating Income | $107.6M | -9.6% |
| Interest Expense | $16.5M | -15.4% |
| Pre-tax Income | -$81.0M | -169.2% |
| Income Tax | $2.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $77.5M | +87.9% |
| Accounts Receivable | $47.4M | +17.2% |
| Inventory | $44.8M | -14.7% |
| Current Assets | $173.9M | +24.8% |
| Total Assets | $473.9M | +135.7% |
| Current Liabilities | $76.3M | +86.6% |
| Long-term Debt | $184.4M | -43.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $129.6M | +24.2% |
| Capital Expenditures | $7.4M | -32.3% |
| Investing Cash Flow | -$9.9M | +9.1% |
| Financing Cash Flow | -$83.4M | -26.7% |
| Free Cash Flow | $122.1M | +30.8% |
| -52.0% |
| Net Income | -$53.7M | -379.2% |
| EPS (Basic) | -$1.22 | -218.4% |
| EPS (Diluted) | -$1.22 | -227.1% |
| Total Liabilities |
| $617.4M |
| +51.8% |
| Stockholders' Equity | -$143.4M | +82.1% |